EXPERIENCE OF OUTPATIENT CENTER FOR PULMONARY HYPERTENSION IN THE SAMARA REGION
https://doi.org/10.17802/2306-1278-2018-7-1-108-113
Abstract
Pulmonary arterial hypertension (PAH) is chronic and progressive disease associated with poor prognosis despite advanced therapeutic options. The choice of adequate treatment requires medical examination as a potential misdiagnosis, particularly in patients present with post-capillary pulmonary hypertension, may result in death. Such patients should be followed up by an experienced healthcare specialist.OutpatientCenterwill allow identifying target patients with early-stage disease or minimizing their risk of complications. The article presents the experience of Outpatient Centre for Pulmonary Hypertension at the Regional Cardiology Dispensary in the Samara region.
About the Authors
N. A. Cherepanova
State Budgetary Healthcare Institution «Samara Regional Clinical Cardiology Dispensary»
Russian Federation
Russian Federation
Corresponding author: Cherepanova Natalia, Russian Federation, 443070, Samara, 43, Aerodromnaya Str.
D. V. Duplyakov
State Budgetary Healthcare Institution «Samara Regional Clinical Cardiology Dispensary»;
Samara State Medical University
Russian Federation
Samara
Russian Federation
Samara
V. P. Kuzmin
State Budgetary Healthcare Institution «Samara Regional Clinical Cardiology Dispensary»
Russian Federation
Samara
Russian Federation
Samara
O. N. Bukhareva
State Budgetary Healthcare Institution «Samara Regional Clinical Cardiology Dispensary»;
Samara State Medical University
Russian Federation
Samara
Russian Federation
Samara
E. A. Suslina
1State Budgetary Healthcare Institution «Samara Regional Clinical Cardiology Dispensary»
Russian Federation
Samara
Russian Federation
Samara
References
1. Hoeper M.M., Bogaard H.J., Condliffe R., Frantz R., Khanna D., Kurzyna M. et al. Definitions and Diagnosis of Pulmonary Hypertension. J Am Coll Cardiol. 2013, 62 (25): 42-50. DOI: 10.1016/j.jacc.2013.10.032
2. Hoeper M.M., Granton J. Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. Am J Respir Crit Care Med., 2011; 184:1114–1124. DOI:10.1164/rccm.201104-0662ci
3. Bazan I.S., Fares W.H. Pulmonary hypertension: diagnostic and therapeutic challenges. Therapeutics and Clinical Risk Management, 2015;11:1221–1233. DOI: 10.2147/TCRM.S74881
4. McLaughlin V.V., Archer S.L., Badesch D.B., Barst R.J., Farber H.W., Lindner J.R. et al. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension. American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association, American College of Chest Physicians, American Thoracic Society, Inc., Pulmonary Hypertension Association. J. Am. Coll. Cardiol, 2009; 53:1573–619. DOI: 10.1016/j.jacc.2009.01.004
5. Humbert M., Sitbon O., Chaouat A., Bertocchi M., Habib G., Gressin V. et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med, 2006; 173: 1023-1030. DOI: 10.1164/rccm.200510-1668OC
6. Peacock A.J., Murphy N.F., McMurray J.J.V., Caballero L., Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J, 2007;30:104-109. DOI: 10.1183/09031936.00092306
7. Pietra G.G., Capron F., Stewart S., Leone O., Humbert M., Robbins I.M., Reid L.M., Tuder R.M. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol, 2004;43:25S–32S. DOI:10.1016/j.jacc.2004.02.033
8. Piazza G, Goldhaber SZ. Chronic Thromboembolic Pulmonary Hypertension. N Engl J Med, 2011; 364(4):351-360. DOI: 10.1056/ NEJMra0910203
9. D’Armini AM. Diagnostic advances and opportunities in chronic thromboembolic pulmonary hypertension: review. Eur Respir Rev, 2015; 24: 253–262. DOI: 10.1183/16000617.00000915
10. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, Gaine S. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol, 2004; 43, 40S-7S. DOI: 10.1016/j.jacc.2004.02.032
11. [Chazova I.E., Martynyuk T.V. Pulmonary hypertension: on the way from rational diagnosis to the choice of effective drug therapy. System Hypertension. 2013; 10(2): 57-69 (In Russ).
12. Galiè N., Humbert M., Vachiery J.L., Gibbs S., Lang I., Torbicki A., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Heart J, 2015; 46: 903–975. DOI:10.1093/eurheartj/ehv317
13. Chazova I.E., Avdeev S.N., Tsareva N.A., Volkov A.V., Martynyuk T. V., Nakonechnikov S.N. on behalf of a Working Group on the Elaboration and Preparation of the Text of Russian Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. Clinical guidelines for the diagnosis and treatment of pulmonary hypertension. Therapeutic archive. 2014; 9: 4-23. (In Russ).
14. Postanovlenie Pravitel’stva RF ot 26.04.2012 N 403 (red. ot 04.09.2012) «O porjadke vedenija Federal’nogo registra lic, stradajushhih zhizneugrozhajushhimi i hronicheskimi progressirujushhimi redkimi (orfannymi) zabolevanijami, privodjashhimi k sokrashheniju prodolzhitel’nosti zhizni grazhdan ili ih invalidnosti, i ego regional’nogo segmenta» Available at: http://www.consultant.ru/document/cons_doc_LAW_129078 (accessed 20.12.2017)(In Russ).
15. Fallah F. Recent Strategies in Treatment of Pulmonary Arterial Hypertension, A Review. Global Journal of Health Science, 2015; 7(4): 307322. DOI: 10.5539/gjhs.v7n4p307
Review
For citations:
Cherepanova N.A., Duplyakov D.V., Kuzmin V.P., Bukhareva O.N., Suslina E.A. EXPERIENCE OF OUTPATIENT CENTER FOR PULMONARY HYPERTENSION IN THE SAMARA REGION. Complex Issues of Cardiovascular Diseases. 2018;7(1):108-113. (In Russ.) https://doi.org/10.17802/2306-1278-2018-7-1-108-113
Views:
759
